HIV Management

The FDA has approved a new HIV medication for use in certain patients who are unable to be successfully treated with other approved HIV medications.

The researchers evaluated the myocardial infarction risk among people with HIV and hepatitis C to understand the impact of both diseases.

In a recent study, researchers examined the lifetime risk of an HIV infection among adults in the United States by ethnic and racial demographics.

Newer antiretroviral therapies exert adverse cardiovascular effects. Therefore, monitoring rates of myocardial infarction by HIV status is critical. In a recent study, researchers examined the national...

In a recent study, researchers compared the safety and efficacy of treating patients with HIV with continuous and intermittent treatment regimens.

In a recent study, researchers examined the impact of a screening program on the incidence of anal squamous cell carcinoma in an at-risk patient population.

The researchers aimed to investigate the impact of early combination antiretroviral therapy initiation on infant viral reservoir size in the setting of high-frequency nonadherence to combination...

The researchers conducted a retrospective cohort study to assess the proportions of children, adolescents, and adults with HIV viral suppression at 1, 2, and 3 years after initiating antiretroviral...

The low-dose tablet is a new formulation of an existing HIV medication already approved for adults.

To conduct their study, the researchers used data from COVID-19 cases reported to the US-based National COVID Cohort Collaborative to evaluate COVID-19 disease severity, hospitalizations, and mortality...